Search

Search Constraints

You searched for: Subject MULTIPLE SCLEROSIS -- NEUROIMMUNOLOGY

Search Results

1. Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis. Issue 12 (19th October 2022)

4. Phase II study of ketogenic diets in relapsing multiple sclerosis: safety, tolerability and potential clinical benefits. Issue 6 (13th April 2022)